Helen Torley - PRESIDENT AND CEO, Director at Halozyme Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
PRESIDENT AND CEO, Director
Stock Symbol
HALO on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Helen Torley - trading volume in the past year for Halozyme Therapeutics, Inc.

Holdings reported by Helen Torley for Halozyme Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 734K $42.4M $57.75 Feb 23, 2025 Direct
Restricted Stock Units 67.3K $3.92M $58.29 Feb 23, 2025 Direct Common Stock
Performance Stock Unit 23.3K $1.31M $56.41 Feb 12, 2025 Direct Common Stock
Option to Purchase Common Stock 93K $1.29M $13.87 Feb 23, 2024 Direct Common Stock
Option to Purchase Common Stock 71K $985K $13.87 Feb 20, 2025 Direct Common Stock
Performance Stock Units 0 $0 $56.41 Feb 16, 2025 Direct Common Stock

Transactions reported by Helen Torley for Halozyme Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.